Teng-Wen Li

Title: Innovations of Teng-Wen Li in MRI Contrast Agents

Introduction

Teng-Wen Li is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of medical imaging, particularly in the development of MRI contrast agents. His work focuses on enhancing the effectiveness and safety of these agents for better diagnostic capabilities.

Latest Patents

One of Teng-Wen Li's key patents is titled "Ligand and metal complex having the same." This invention involves a ligand and a metal complex that exhibits high stability, high relaxivity, and high biocompatibility. The metal complex is particularly applicable in the preparation of MRI contrast agents for detecting atherosclerosis. The innovative MRI contrast agent includes a peptide sequence that is specific to a matrix metalloprotease, allowing it to be recognized by pathological thrombocytes. This targeting capability enhances the imaging contrast, making it a valuable tool in medical diagnostics.

Career Highlights

Teng-Wen Li is affiliated with National Yang Ming Chiao Tung University, where he continues to advance research in medical imaging technologies. His work has garnered attention for its potential to improve patient outcomes through more accurate imaging techniques.

Collaborations

Teng-Wen Li has collaborated with esteemed colleagues such as Chiao-Yun Chen and Gin-Chung Liu. Their joint efforts contribute to the ongoing research and development in the field of MRI contrast agents.

Conclusion

Teng-Wen Li's innovative work in the development of MRI contrast agents showcases his commitment to enhancing medical imaging technologies. His contributions are paving the way for improved diagnostic methods in healthcare.